Search
for
Sort by
Research 481–510 of 1000+
- Physiological Doses of Red Light Induce IL‐4 Release in Cocultures between Human Keratinocytes and Immune Cells
- Cicatricial (Scarring) Alopecias
- Skin disease in pregnancy
- Nonvascular Complications of Injectable Fillers—Prevention and Management
- A CLINICAL STUDY OF MUCOCUTANEOUS MANIFESTATIONS OF HIV
- Alopecia Areata and Alopecia Areata Incognita
- Dermatological Manifestations of COVID-19: A Brief Review
- Distinctive histopathologic findings in linear morphea (<i>en coup de sabre</i>) alopecia
- Alopecia-associated pseudocyst of the scalp
- Caution with Hair Dye: Foreign Body Skull Erosive Granuloma from Exogenous Hair Pigmentation
- Disorders of hair in children
- Erosive pustular dermatosis of the scalp: Clinical, trichoscopic, and histopathologic features of 20 cases
- Updated diagnostic criteria for frontal fibrosing alopecia
- Topical tofacitinib solution for the treatment of alopecia areata affecting eyelashes
- Dermatology and Pregnancy
- Loose anagen hair of childhood: The phenomenon of easily pluckable hair
- Dermal mucin in alopecia areata – tell tale sign or incidental finding?
- Frontal fibrosing alopecia in Asians: a retrospective clinical study
- Interferon alfa-2a in the treatment of cutaneous T cell lymphoma
- Adverse Cutaneous Reactions to Mood Stabilizers
- Procyanidin B-2, extracted from apples, promotes hair growth: a laboratory study
- Localization of varicella-zoster virus nucleic acids and proteins in human skin
- The in vitro plasticity of hair follicle dermal and mesenchymal stem cells
- Tofacitinib for the treatment of alopecia areata and variants in adolescents
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- Cutaneous and Mucosal Manifestations Associated with Celiac Disease
- Pathogenesis and treatment options for chemotherapy‐induced alopecia: a systematic review
- Treatment of severe alopecia areata with baricitinib
- The histopathology of alopecia areata in vertical and horizontal sections
- “Nail loss after teriflunomide treatment: A new potential adverse event”